NIH-funded research NIH-funded research

Swine Somatic Cell Genome Editing Center

Official title: Swine Somatic Cell Gene Editing Testing Center

Funded at University of Missouri-Columbia · NIH-11393739 · Data updated 2026-11-12

A center that helps researchers work with edited pig cells and animals to study genome editing safely and efficiently, with the aim of advancing basic science and future clinical applications.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startSeptember 12, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$1,328,901
NIH project number5U42OD035738-04
Project IDNIH-11393739 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patients directly; however, future clinical benefits may arise from translational research using swine genome-editing models.

Less likely to help

People currently seeking immediate treatments may not participate in this program.

What this research studies

This NIH-funded center provides services to produce, import, cryopreserve, and supply swine models used in somatic cell genome editing research. It also evaluates how safe and effective genome-editing strategies are and explores when therapies might work best and for how long. The center coordinates communication, logistics, and regulatory reporting, while maintaining BSL-2 facilities and breeding colonies to support researchers. By testing new delivery methods and reagents, the center aims to accelerate both basic research and the translation of therapies toward clinic use. Researchers and institutions can collaborate through a structured framework that connects model production, testing, and translational potential.

Why it matters

Potential benefit: If successful, this center could speed the development of genome-edited therapies by providing robust swine models and safer, more effective delivery methods.

How similar studies have gone: Previous genome editing centers have shown that standardized swine models and testing can accelerate therapeutic development, though this project focuses on building and validating a specialized testing center.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Green, Jonathan a — University of Missouri-Columbia
  • Study coordinator: Green, Jonathan a

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.